13 Eyl Nimsai Herbal Phase III Clinical Study Report
Clinical Study Reportİndir ...
Author: admin
18 Haz Clinical Trial Study Protocol
Protocol Title: A Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Randomized Clinical Trial Investigating the Efficacy and Safety of a 10-Day Oral Nimsai Herbal Treatment in Patients with Grade 2-3 Hemorrhoids, Based on the War-Drill Model and the Sine Qua Non Hypothesis Protocol Number: NA-2024-01 Protocol Version: 1.1 Date: October 14,...
18 Haz CONSORT 2025 Flow Diagram
.box { border: 1px solid #000; padding: 10px; margin: 10px auto; width: 300px; text-align:...
18 Haz CONSORT 2025 Editable Checklist
Section/topicNoCONSORT 2025 checklist item descriptionReported on page no.Title and abstractTitle and abstractTitle and abstractTitle and structured abstract1aIdentification as a randomised trialTitle, AbstractTitle and structured abstract1bStructured summary of the trial design, methods, results, and conclusionsAbstractOpen scienceOpen scienceOpen scienceTrial registration2Name of trial registry, identifying number (with URL)...
18 Haz Clinical Trial Study Protocol
Protocol Title: A Prospective, Double-Blind Diagnostic Accuracy Study of the Parola Phenomenon in Patients with Symptomatic Hemorrhoids Protocol Number: S1 (Supplementary Protocol 1) Protocol Version: 1.0 Date: Oct 14, 2021 Investigators: Cem Atabiner, Nimsai Academia Principal Investigator Nimsai Academia Anal Fissure-Hemorrhoid Research Team Affiliation: Nimsai Academia, Türkiye Corresponding Investigator: Cem Atabiner, info@nimsai.com 1. Introduction and Rationale The...
18 Haz APPENDIX C: INVESTIGATOR BROCHURE FOR NIMSAI HERBAL (Condensed)
Product Name: Nimsai Herbal Protocol Number: NA-2024-01 Date: Oct 14, 2021 1. INTRODUCTION TO NIMSAI HERBAL Nimsai Herbal is a novel, proprietary oral herbal formulation developed by Nimsai Academia for the systemic management of hemorrhoidal disease. It is hypothesized to target underlying venous congestion, a critical factor in hemorrhoid...
18 Haz APPENDIX B: CASE REPORT FORMS (CRFs) TEMPLATE
Study Protocol Number: NA-2024-01 Participant ID: Site ID: CRF Section 1: Screening & Baseline Demographics (Day 0) Participant ID: ___________ Date of Birth: __/__/____ (DD/MM/YYYY) Age (Years): ____ Gender: [ ] Male [ ] Female Ethnicity: [ ] Caucasian [ ] Asian [ ] African [ ] Other: ______ Medical History (Relevant): IBD: [...
18 Haz APPENDIX A: INFORMED CONSENT FORM
Protocol Title: A Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Randomized Clinical Trial Investigating the Efficacy and Safety of a 10-Day Oral Nimsai Herbal Treatment in Patients with Grade 2-3 Hemorrhoids, Based on the War-Drill Model and the Sine Qua Non Hypothesis Protocol Number: NA-2024-01 Version: 1.1 Date: Oct 14, 2021 Investigator:...